Plasma prolactin and homovanillic acid as markers for psychopathology and abnormal movements after neuroleptic dose decrease

J. W. Newcomer*, S. J. Riney, S. Vinogradov, J. G. Csernansky

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

Plasma prolactin concentration (pPRL), plasma homovanillic acid concentration (pHVA), and symptomatology were measured in 24 male subjects with schizophrenia during maintenance haloperidol treatment. Fourteen subjects subsequently underwent 50 percent dose decreases under placebo- controlled, double-blind conditions. At baseline, a significant inverse correlation was found between pPRL and both tardive dyskinesia (TD) and 'thinking disorder'; pPRL was directly correlated with negative symptoms. No such relationship was found with pHVA. In the patients who underwent a dose decrease, no relationship was found between baseline pPRL or pHVA and any clinical variable after the decrease. These data do not support the use of baseline pPRL or pHVA as markers of central dopamine function subsequent to a neuroleptic dose decrease.

Original languageEnglish (US)
Pages (from-to)101-107
Number of pages7
JournalPsychopharmacology bulletin
Volume28
Issue number1
StatePublished - 1992

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Plasma prolactin and homovanillic acid as markers for psychopathology and abnormal movements after neuroleptic dose decrease'. Together they form a unique fingerprint.

Cite this